The 1 analysts offering 12-month price forecasts for InMed Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +182.49% increase from the last price of 7.08.
The current consensus among 1 polled investment analysts is to Hold stock in InMed Pharmaceuticals Inc. This rating has held steady since May, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$5.50
Reporting Date Sep 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.